Imunon Appoints James E. Dentzer to its Board of Directors
03.10.2022 - CEO of Curis brings extensive biopharmaceutical financial experience to the Board LAWRENCEVILLE, N.J., Oct. 03, 2022 (GLOBE NEWSWIRE) - Imunon, Inc. (Nasdaq: IMNN), a clinical-stage drug development company, announces the appointment of James E. ... Seite 1
Michaelh Tardugno Jamese Dentzer Board Of Directors Curis Inc Imunon Inc Nasdaq Valeritas Inc Biogen Inc
Source: wallstreet-online.de